Neurological manifestations of COVID-19 infection in acute and late phases: A case-control study

• Published in: Neurology Asia Vol. 28; no. 1; pp. 141 - 148
• Main Authors: Ekmekyapar Fırat, Yasemin, Kılıçparlar Cengiz, Emine, Neyal, Abdurrahman, Günel Karadeniz, Pınar, Arı Yılmaz, Demet, Demirbakan, Hadiye, Neyal, Ayşe Münife
• Format: Journal Article
• Language: English
• Published: 01.03.2023
• ISSN: 1823-6138
• DOI: 10.54029/2023jrc

Background & Objective: The late-term neurological effects of COVID-19 are not fully understood yet. Herein, we aimed to determine if COVID-19-related acute and late-term neurological symptoms exist in the patient group that differs from the general population during the pandemic period. Methods: Two hundred fifty patients with a history of COVID-19, whose treatments were completed at least one month before enrollment, were examined together with a control group consisting of 150 individuals that lived in the same socio-cultural environment during the same period. A survey that included questions about possible neurological symptoms that might be related to the COVID-19 infection was completed in both groups. Results: The patient and control groups were mostly similar regarding the neurological symptoms in the pre-pandemic period. The control group did not report any new symptoms except ageusia during the pandemic period. Whereas a number of neurological symptoms such as headache, ageusia and anosmia, difficulty in thinking and planning, forgetfulness, clumsiness of one or both hands, dizziness, unsteadiness, numbness in both hands and feet, and neuropathic pain occurred during the infection. Neurological symptoms, except headache and unsteadiness, prolonged to the late-term with a decreased prevalence. Conclusion: The emergence of new neurological symptoms during the pandemic in those with COVID-19 disease, unlike the control group, suggested that these symptoms are related to the infection itself.